Recent News

• 06.11.2025 - Sidoti Small Cap Conference
• 06.10.2025 - Presentation at Q2 Investor Summit
• 06.05.2025 - Nanox Receives MDR CE Mark for HealthOST, an Advanced AI-Powered Software for Spine Assessment
• 06.03.2025 - Nanox to Participate in Sidoti Small Cap Conference
• 05.22.2025 - First Quarter 2025 Financial and Operating Results
• 05.22.2025 - Nanox Announces First Quarter 2025 Financial Results and Provides Business Updates
• 05.08.2025 - Nanox to Report First Quarter 2025 Financial Results on May 22, 2025
• 04.17.2025 - Nanox Receives FDA Clearance for General Use of New Imaging System, Nanox.ARC X
• 03.31.2025 - Fourth Quarter 2024 Financial and Operating Results
• 03.31.2025 - Nanox Announces Fourth Quarter of 2024 Financial Results and Provides Business Updates

Recent Filings

• 05.22.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 05.22.2025 - EX-99.1 EX-99.1
• 04.17.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 04.17.2025 - EX-99.1 EX-99.1
• 04.09.2025 - 20-F Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
• 03.31.2025 - 6-K Report of foreign issuer [Rules 13a-16 and 15d-16]
• 03.31.2025 - EX-99.1 EX-99.1